Jodi Devlin, Chief of Clinical Operations at TriSalus Life Sciences, Inc. (TLSI), sold 3,207 shares at $4.13 ($13K) on 2026-03-11, disclosed to the SEC on 2026-03-20.
Open-market sale of $13k TLSI by Chief of Clinical Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.13 | 1,162 | $5K | 36.4% |
| 2 | $4.09 | 1,772 | $7K | 55.0% |
| 3 | $4.12 | 273 | $1K | 8.5% |
| Total | $4.11 avg | 3,207 | $13K | 100% |